Literature DB >> 17827958

Risk factors of chronic pancreatitis.

Generoso Uomo1, Gianpiero Manes.   

Abstract

Chronic pancreatitis (CP) still remains a challenging clinical problem with many controversial issues regarding pathogenesis, outcome, and treatment. The disease comprises a spectrum of disorders that culminate as a final step in the destruction of the pancreas. Complex interaction does exist between genetic, environmental and immunologic factors leading to development of the disease. Multiple risk factors interact in a multiple-step model; the pancreatic injury may occur through different mechanisms with transition between an acute pancreatitis condition to recurrent pancreatitis and, finally, to CP. Most patients have multiple risk factors and the overall risk is a product of all risk factors in additive or multiplicative fashion. Susceptibility to develop CP in alcoholics depends on the expression of single gene mutation or is derived from complex genetic polymorphism; in addition, smoking habit can influence the risk of pancreatic calcifications and severity in alcoholic and idiopathic CP. Alteration of the immune response induced by gene mutations and/or environmental factors represents the main determinant of pancreatic fibrosis, the end-stage histologic feature from all CP etiologies. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17827958     DOI: 10.1159/000103903

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

1.  Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.

Authors:  Dana K Andersen; Åke Andren-Sandberg; Eric J Duell; Michael Goggins; Murray Korc; Gloria M Petersen; Jill P Smith; David C Whitcomb
Journal:  Pancreas       Date:  2013-11       Impact factor: 3.327

2.  Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  E Lucenteforte; C La Vecchia; D Silverman; G M Petersen; P M Bracci; B T Ji; C Bosetti; D Li; S Gallinger; A B Miller; H B Bueno-de-Mesquita; R Talamini; J Polesel; P Ghadirian; P A Baghurst; W Zatonski; E Fontham; W R Bamlet; E A Holly; Y T Gao; E Negri; M Hassan; M Cotterchio; J Su; P Maisonneuve; P Boffetta; E J Duell
Journal:  Ann Oncol       Date:  2011-05-02       Impact factor: 32.976

3.  Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  E J Duell; E Lucenteforte; S H Olson; P M Bracci; D Li; H A Risch; D T Silverman; B T Ji; S Gallinger; E A Holly; E H Fontham; P Maisonneuve; H B Bueno-de-Mesquita; P Ghadirian; R C Kurtz; E Ludwig; H Yu; A B Lowenfels; D Seminara; G M Petersen; C La Vecchia; P Boffetta
Journal:  Ann Oncol       Date:  2012-07-05       Impact factor: 32.976

4.  Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis.

Authors:  Frederic Marrache; Shui Ping Tu; Govind Bhagat; Swaroop Pendyala; Christoph H Osterreicher; Shanisha Gordon; Vigneshwaran Ramanathan; Melitta Penz-Osterreicher; Kelly S Betz; Zhigang Song; Timothy C Wang
Journal:  Gastroenterology       Date:  2008-07-01       Impact factor: 22.682

5.  A comprehensive study indicates PRSS1 gene is significantly associated with pancreatitis.

Authors:  Jie Liu; Hong-xin Zhang
Journal:  Int J Med Sci       Date:  2013-06-13       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.